PROmyBETAapp: Ascertaining Medication Usage & Documentation of Patient Reported Outcomes Utilizing the myBETAapp® in Patients With Multiple Sclerosis Treated With Betaferon®: a Pilot Study
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms PROmyBETAapp
- Sponsors Bayer
- 10 Oct 2017 Status changed from not yet recruiting to recruiting.
- 28 Aug 2017 Planned End Date changed from 31 Jan 2018 to 31 May 2018.
- 28 Aug 2017 Planned primary completion date changed from 31 Jan 2018 to 31 May 2018.